The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Clinova’s corporate website, SEC filings, investor presentations and featured press releases, both from Clinova and market -specific third party sources, put together by Global Industries Direct’s team.

Scope of the Research

- Clinova - Brief Clinova overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Clinova human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Clinova with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Clinova’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Clinova’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Clinova in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Clinova’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Clinova.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Clinova and identify potential opportunities in those areas.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Clinova Snapshot 4
Clinova Overview 4
Key Information 4
Key Facts 4
Clinova - Research and Development Overview 5
Key Therapeutic Areas 5
Clinova - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Clinova - Pipeline Products Glance 9
Clinova - Late Stage Pipeline 9
Phase III Products/Combination Treatment Modalities 9
Clinova - Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Clinova - Drug Profiles 11
CLIN 3004 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
CLIN 3007 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
CLIN 3010 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
CLIN 3011 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Clinova - Pipeline Analysis 15
Clinova - Pipeline Products by Therapeutic Class 15
Clinova - Pipeline Products by Molecule Type 16
Clinova - Firms Statement 17
Clinova - Locations And Subsidiaries 18
Head Office 18
Other Locations and Subsidiaries 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 20
Expert Panel Validation 20
Contact Us 20
Disclaimer 20

List of Tables

Clinova, Facts and Figures 4
Clinova, Key Facts 4
Clinova - Pipeline by Therapy Area and Indication, H2 2011 6
Clinova - Pipeline by Stage of Development, H2 2011 7
Clinova - Monotherapy Products in Pipeline, H2 2011 8
Clinova - Phase III, H2 2011 9
Clinova - Pre-Clinical, H2 2011 10
Clinova - Pipeline By Therapeutic Class, H2 2011 15
Clinova - Pipeline By Molecule Type, H2 2011 16
Clinova, Other Locations 18

List of Figures

Clinova - Pipeline by Therapy Area and Indication, H2 2011 6
Clinova - Pipeline by Stage of Development, H2 2011 7
Clinova - Monotherapy Products in Pipeline, H2 2011 8
Clinova - Pipeline By Therapeutic Class, H2 2011 15

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...

Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.